Literature DB >> 11129424

Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients.

M Tachibana1, T Kotoh, S Kinugasa, D K Dhar, M Shibakita, S Ohno, R Masunaga, H Kubota, H Kohno, N Nagasue.   

Abstract

BACKGROUND: Patients with cirrhosis of the liver sometimes are candidates for esophagectomy with extensive lymphadenectomy.
MATERIALS AND METHODS: Of 271 patients with primary esophageal carcinoma, 19 patients (7.0%) had pathologically proven cirrhosis of the liver. Among those, 18 patients underwent esophagectomy with extensive lymph node dissection. Clinicopathologic characteristics of these 18 patients were retrospectively investigated.
RESULTS: Pathological T stages were pT1 in 3 patients, pT2 in 9 patients, pT3 in 2 patients, and pT4 in 4 patients. Hepatitis C virus antibody was positive in 1 patient, and 14 patients were alcoholics. Three patients had cryptogenic cirrhosis. Seven patients were classified as Child-Turcotte B and 11 were Child-Turcotte A. Three patients had ICG-R 15 over 30%. Fifteen patients (83.3%) developed a total of 35 postoperative complications. Three patients currently are alive without recurrence. Fifteen patients have died: 7 from cancer recurrence; 5 of causes unrelated to esophageal cancer; and 3 of operative death (operative mortality: 16.7% in 18 cirrhotic patients vs. 5.7% in 227 non-cirrhotic patients; P = .102). The 1- and 3-year survival rates for 18 resected cirrhotic patients were 50% and 21%, respectively, and those for 227 resected non-cirrhotic patients were 67% and 42%, respectively (P = .051). When operative deaths were excluded from the analysis, the 1- and 3-year survival rates for 15 cirrhotic patients were 60% and 25%, respectively, whereas those for 214 non-cirrhotic patients were 68% and 43%, respectively (P = .271).
CONCLUSION: Although cirrhosis has a high morbidity and mortality rate, Child-Turcotte A and B cirrhosis may not contraindicate curative esophagectomy for esophageal carcinoma. However, these patients need meticulous perioperative care to avoid postoperative complications.

Entities:  

Mesh:

Year:  2000        PMID: 11129424     DOI: 10.1007/s10434-000-0758-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Mediastinoscopy-assisted esophagectomy for esophageal cancer in patients with serious comorbidities.

Authors:  Naohiko Koide; Daisuke Takeuchi; Akira Suzuki; Shinichi Miyagawa
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Barrett's adenocarcinoma with esophageal varices successfully treated by endoscopic submucosal dissection with direct varices coagulation.

Authors:  Chise Ueda; Tetsuya Yosizaki; Norio Katayama; Norihiro Okamoto; Hiroki Hashimura; Masanori Matsumoto; Megumi Takagi; Seitaro Ikeoka; Kenji Momose; Takaaki Eguchi; Hiroshi Yamashita; Akihiko Okada
Journal:  Clin J Gastroenterol       Date:  2019-09-26

3.  Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Andrea Ruzzenente; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

Review 4.  [Anesthesia with liver failure].

Authors:  Eva-Lotte Camboni-Schellenberg; Barbara Sinner
Journal:  Anaesthesist       Date:  2016-01       Impact factor: 1.041

5.  Outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms in patients with liver cirrhosis.

Authors:  Young Kwon Choi; Jin Hee Noh; Do Hoon Kim; Hee Kyong Na; Ji Yong Ahn; Jeong Hoon Lee; Kee Wook Jung; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  Clin Endosc       Date:  2022-04-20

6.  Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis.

Authors:  Yung-Kuan Tsou; Chia-Yuan Liu; Kuang-I Fu; Cheng-Hui Lin; Mu-Shien Lee; Ming-Yao Su; Ken Ohata; Cheng-Tang Chiu
Journal:  Dig Dis Sci       Date:  2016-10-21       Impact factor: 3.199

7.  Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience.

Authors:  Julia K Grass; Natalie Küsters; Marius Kemper; Jan Tintrup; Felix Piecha; Jakob R Izbicki; Daniel Perez; Nathaniel Melling; Maximilian Bockhorn; Matthias Reeh
Journal:  PLoS One       Date:  2022-03-09       Impact factor: 3.240

8.  Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis.

Authors:  Florence Trivin; Eveline Boucher; Elodie Vauléon; Isabelle Cumin; Elisabeth Le Prisé; Odile Audrain; Jean-Luc Raoul
Journal:  J Oncol       Date:  2009-12-22       Impact factor: 4.375

9.  Is there a place for esogastric cancer surgery in cirrhotic patients?

Authors:  Christophe Mariette
Journal:  Ann Surg Oncol       Date:  2008-01-03       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.